APO Research
Talk to an analyst

APO RESEARCH · REPORT

RGD Peptide

Compare research editions
View pricing & licenses

Selected research

Industry Research

RGD Peptide Industry Research Report 2026

30 December 2025133 pages

Choose your research edition.

Industry ResearchRGD Peptide Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal RGD Peptide Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal RGD Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RGD Peptide Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal RGD Peptide Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global RGD Peptide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for RGD Peptide is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for RGD Peptide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for RGD Peptide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of RGD Peptide include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global RGD Peptide market in revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to RGD Peptide.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

RGD Peptide Market by Company

Wuhan Tanda Biotechnology

XIAN RUIXI

QYAOBIO

TGpeptide

Merck KGaA

Allpeptide

TargetMol Chemicals

Santa Cruz Animal Health

PEPTIDE INSTITUTE

Novatein Biosciences

Enzo

Cell Guidance Systems

CD Bioparticles

Bio-Techne

BICO(Advanced BioMatrix)

ApexBio Technology

AnaSpec

Abbiotec

RGD Peptide Segment by Type

RGD Cyclic Peptide

Linear RGD Peptide

RGD Peptide Segment by Application

Pharmaceuticals

Scientific Research

RGD Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RGD Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RGD Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RGD Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of RGD Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of RGD Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of RGD Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global RGD Peptide Production by Manufacturers (L) & (2021-2026) Table 6. Global RGD Peptide Production Market Share by Manufacturers Table 7. Global RGD Peptide Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global RGD Peptide Production Value Market Share by Manufacturers (2021-2026) Table 9. Global RGD Peptide Average Price (US$/mL) of Manufacturers (2021-2026) Table 10. Global RGD Peptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global RGD Peptide Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global RGD Peptide Manufacturers, Product Type & Application Table 13. Global RGD Peptide Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global RGD Peptide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Wuhan Tanda Biotechnology Company Information Table 18. Wuhan Tanda Biotechnology Business Overview Table 19. Wuhan Tanda Biotechnology RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 20. Wuhan Tanda Biotechnology RGD Peptide Product Portfolio Table 21. Wuhan Tanda Biotechnology Recent Development Table 22. XIAN RUIXI Company Information Table 23. XIAN RUIXI Business Overview Table 24. XIAN RUIXI RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 25. XIAN RUIXI RGD Peptide Product Portfolio Table 26. XIAN RUIXI Recent Development Table 27. QYAOBIO Company Information Table 28. QYAOBIO Business Overview Table 29. QYAOBIO RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 30. QYAOBIO RGD Peptide Product Portfolio Table 31. QYAOBIO Recent Development Table 32. TGpeptide Company Information Table 33. TGpeptide Business Overview Table 34. TGpeptide RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 35. TGpeptide RGD Peptide Product Portfolio Table 36. TGpeptide Recent Development Table 37. Merck KGaA Company Information Table 38. Merck KGaA Business Overview Table 39. Merck KGaA RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 40. Merck KGaA RGD Peptide Product Portfolio Table 41. Merck KGaA Recent Development Table 42. Allpeptide Company Information Table 43. Allpeptide Business Overview Table 44. Allpeptide RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 45. Allpeptide RGD Peptide Product Portfolio Table 46. Allpeptide Recent Development Table 47. TargetMol Chemicals Company Information Table 48. TargetMol Chemicals Business Overview Table 49. TargetMol Chemicals RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 50. TargetMol Chemicals RGD Peptide Product Portfolio Table 51. TargetMol Chemicals Recent Development Table 52. Santa Cruz Animal Health Company Information Table 53. Santa Cruz Animal Health Business Overview Table 54. Santa Cruz Animal Health RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 55. Santa Cruz Animal Health RGD Peptide Product Portfolio Table 56. Santa Cruz Animal Health Recent Development Table 57. PEPTIDE INSTITUTE Company Information Table 58. PEPTIDE INSTITUTE Business Overview Table 59. PEPTIDE INSTITUTE RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 60. PEPTIDE INSTITUTE RGD Peptide Product Portfolio Table 61. PEPTIDE INSTITUTE Recent Development Table 62. Novatein Biosciences Company Information Table 63. Novatein Biosciences Business Overview Table 64. Novatein Biosciences RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 65. Novatein Biosciences RGD Peptide Product Portfolio Table 66. Novatein Biosciences Recent Development Table 67. Enzo Company Information Table 68. Enzo Business Overview Table 69. Enzo RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 70. Enzo RGD Peptide Product Portfolio Table 71. Enzo Recent Development Table 72. Cell Guidance Systems Company Information Table 73. Cell Guidance Systems Business Overview Table 74. Cell Guidance Systems RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 75. Cell Guidance Systems RGD Peptide Product Portfolio Table 76. Cell Guidance Systems Recent Development Table 77. CD Bioparticles Company Information Table 78. CD Bioparticles Business Overview Table 79. CD Bioparticles RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 80. CD Bioparticles RGD Peptide Product Portfolio Table 81. CD Bioparticles Recent Development Table 82. Bio-Techne Company Information Table 83. Bio-Techne Business Overview Table 84. Bio-Techne RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 85. Bio-Techne RGD Peptide Product Portfolio Table 86. Bio-Techne Recent Development Table 87. BICO(Advanced BioMatrix) Company Information Table 88. BICO(Advanced BioMatrix) Business Overview Table 89. BICO(Advanced BioMatrix) RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 90. BICO(Advanced BioMatrix) RGD Peptide Product Portfolio Table 91. BICO(Advanced BioMatrix) Recent Development Table 92. ApexBio Technology Company Information Table 93. ApexBio Technology Business Overview Table 94. ApexBio Technology RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 95. ApexBio Technology RGD Peptide Product Portfolio Table 96. ApexBio Technology Recent Development Table 97. AnaSpec Company Information Table 98. AnaSpec Business Overview Table 99. AnaSpec RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 100. AnaSpec RGD Peptide Product Portfolio Table 101. AnaSpec Recent Development Table 102. Abbiotec Company Information Table 103. Abbiotec Business Overview Table 104. Abbiotec RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 105. Abbiotec RGD Peptide Product Portfolio Table 106. Abbiotec Recent Development Table 107. Global RGD Peptide Production Comparison by Region: 2021 VS 2025 VS 2032 (L) Table 108. Global RGD Peptide Production by Region (2021-2026) & (L) Table 109. Global RGD Peptide Production Market Share by Region (2021-2026) Table 110. Global RGD Peptide Production Forecast by Region (2027-2032) & (L) Table 111. Global RGD Peptide Production Market Share Forecast by Region (2027-2032) Table 112. Global RGD Peptide Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Global RGD Peptide Production Value by Region (2021-2026) & (US$ Million) Table 114. Global RGD Peptide Production Value Market Share by Region (2021-2026) Table 115. Global RGD Peptide Production Value Forecast by Region (2027-2032) & (US$ Million) Table 116. Global RGD Peptide Market Average Price (US$/mL) by Region (2021-2026) Table 117. Global RGD Peptide Market Average Price (US$/mL) by Region (2027-2032) Table 118. Global RGD Peptide Consumption Comparison by Region: 2021 VS 2025 VS 2032 (L) Table 119. Global RGD Peptide Consumption by Region (2021-2026) & (L) Table 120. Global RGD Peptide Consumption Market Share by Region (2021-2026) Table 121. Global RGD Peptide Forecasted Consumption by Region (2027-2032) & (L) Table 122. Global RGD Peptide Forecasted Consumption Market Share by Region (2027-2032) Table 123. North America RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 124. North America RGD Peptide Consumption by Country (2021-2026) & (L) Table 125. North America RGD Peptide Consumption by Country (2027-2032) & (L) Table 126. Europe RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 127. Europe RGD Peptide Consumption by Country (2021-2026) & (L) Table 128. Europe RGD Peptide Consumption by Country (2027-2032) & (L) Table 129. Asia Pacific RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 130. Asia Pacific RGD Peptide Consumption by Country (2021-2026) & (L) Table 131. Asia Pacific RGD Peptide Consumption by Country (2027-2032) & (L) Table 132. South America, Middle East & Africa RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 133. South America, Middle East & Africa RGD Peptide Consumption by Country (2021-2026) & (L) Table 134. South America, Middle East & Africa RGD Peptide Consumption by Country (2027-2032) & (L) Table 135. Global RGD Peptide Production by Type (2021-2026) & (L) Table 136. Global RGD Peptide Production by Type (2027-2032) & (L) Table 137. Global RGD Peptide Production Market Share by Type (2021-2026) Table 138. Global RGD Peptide Production Market Share by Type (2027-2032) Table 139. Global RGD Peptide Production Value by Type (2021-2026) & (US$ Million) Table 140. Global RGD Peptide Production Value by Type (2027-2032) & (US$ Million) Table 141. Global RGD Peptide Production Value Market Share by Type (2021-2026) Table 142. Global RGD Peptide Production Value Market Share by Type (2027-2032) Table 143. Global RGD Peptide Price by Type (2021-2026) & (US$/mL) Table 144. Global RGD Peptide Price by Type (2027-2032) & (US$/mL) Table 145. Global RGD Peptide Production by Application (2021-2026) & (L) Table 146. Global RGD Peptide Production by Application (2027-2032) & (L) Table 147. Global RGD Peptide Production Market Share by Application (2021-2026) Table 148. Global RGD Peptide Production Market Share by Application (2027-2032) Table 149. Global RGD Peptide Production Value by Application (2021-2026) & (US$ Million) Table 150. Global RGD Peptide Production Value by Application (2027-2032) & (US$ Million) Table 151. Global RGD Peptide Production Value Market Share by Application (2021-2026) Table 152. Global RGD Peptide Production Value Market Share by Application (2027-2032) Table 153. Global RGD Peptide Price by Application (2021-2026) & (US$/mL) Table 154. Global RGD Peptide Price by Application (2027-2032) & (US$/mL) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. RGD Peptide Distributors List Table 158. RGD Peptide Customers List Table 159. RGD Peptide Industry Trends Table 160. RGD Peptide Industry Drivers Table 161. RGD Peptide Industry Restraints Table 162. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. RGD Peptide Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. RGD Cyclic Peptide Product Image Figure 7. Linear RGD Peptide Product Image Figure 8. Pharmaceuticals Product Image Figure 9. Scientific Research Product Image Figure 10. Global RGD Peptide Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 12. Global RGD Peptide Production Capacity (2021-2032) & (L) Figure 13. Global RGD Peptide Production (2021-2032) & (L) Figure 14. Global RGD Peptide Average Price (US$/mL) & (2021-2032) Figure 15. Global RGD Peptide Key Manufacturers, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 RGD Peptide Players Market Share by Production Value in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global RGD Peptide Production Comparison by Region: 2021 VS 2025 VS 2032 (L) Figure 19. Global RGD Peptide Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global RGD Peptide Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global RGD Peptide Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America RGD Peptide Production Value (US$ Million) Growth Rate (2021-2032) Figure 23. Europe RGD Peptide Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. China RGD Peptide Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. Japan RGD Peptide Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Global RGD Peptide Consumption Comparison by Region: 2021 VS 2025 VS 2032 (L) Figure 27. Global RGD Peptide Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 29. North America RGD Peptide Consumption Market Share by Country (2021-2032) Figure 30. United States RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 31. United States RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 32. Canada RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 33. Europe RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 34. Europe RGD Peptide Consumption Market Share by Country (2021-2032) Figure 35. Germany RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 36. France RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 37. U.K. RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 38. Italy RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 39. Netherlands RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 40. Asia Pacific RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 41. Asia Pacific RGD Peptide Consumption Market Share by Country (2021-2032) Figure 42. China RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 43. Japan RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 44. South Korea RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 45. India RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 46. Australia RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 47. China Taiwan RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 48. Southeast Asia RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 49. South America, Middle East & Africa RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 50. South America, Middle East & Africa RGD Peptide Consumption Market Share by Country (2021-2032) Figure 51. Brazil RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 52. Argentina RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 53. Chile RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 54. Turkey RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 55. GCC Countries RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 56. Global RGD Peptide Production Market Share by Type (2021-2032) Figure 57. Global RGD Peptide Production Value Market Share by Type (2021-2032) Figure 58. Global RGD Peptide Price (US$/mL) by Type (2021-2032) Figure 59. Global RGD Peptide Production Market Share by Application (2021-2032) Figure 60. Global RGD Peptide Production Value Market Share by Application (2021-2032) Figure 61. Global RGD Peptide Price (US$/mL) by Application (2021-2032) Figure 62. RGD Peptide Value Chain Figure 63. RGD Peptide Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. RGD Peptide Industry Opportunities and Challenges

Scope & coverage.

Types
  • RGD Cyclic Peptide
  • Linear RGD Peptide
Applications
  • Pharmaceuticals
  • Scientific Research
Companies covered
  • Wuhan Tanda Biotechnology
  • XIAN RUIXI
  • QYAOBIO
  • TGpeptide
  • Merck KGaA
  • Allpeptide
  • TargetMol Chemicals
  • Santa Cruz Animal Health
  • PEPTIDE INSTITUTE
  • Novatein Biosciences
  • Enzo
  • Cell Guidance Systems
  • CD Bioparticles
  • Bio-Techne
  • BICO(Advanced BioMatrix)
  • ApexBio Technology
  • AnaSpec
  • Abbiotec

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 RGD Peptide by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 RGD Cyclic Peptide
  5. 2.2.3 Linear RGD Peptide
  6. 2.3 RGD Peptide by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pharmaceuticals
  9. 2.3.3 Scientific Research
  10. 2.4 Global Market Growth Prospects
  11. 2.4.1 Global RGD Peptide Production Value Estimates and Forecasts (2021-2032)
  12. 2.4.2 Global RGD Peptide Production Capacity Estimates and Forecasts (2021-2032)
  13. 2.4.3 Global RGD Peptide Production Estimates and Forecasts (2021-2032)
  14. 2.4.4 Global RGD Peptide Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global RGD Peptide Production by Manufacturers (2021-2026)
  2. 3.2 Global RGD Peptide Production Value by Manufacturers (2021-2026)
  3. 3.3 Global RGD Peptide Average Price by Manufacturers (2021-2026)
  4. 3.4 Global RGD Peptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RGD Peptide Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global RGD Peptide Manufacturers, Product Type & Application
  7. 3.7 Global RGD Peptide Manufacturers Established Date
  8. 3.8 Global RGD Peptide Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Wuhan Tanda Biotechnology
  2. 4.1.1 Wuhan Tanda Biotechnology RGD Peptide Company Information
  3. 4.1.2 Wuhan Tanda Biotechnology RGD Peptide Business Overview
  4. 4.1.3 Wuhan Tanda Biotechnology RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Wuhan Tanda Biotechnology Product Portfolio
  6. 4.1.5 Wuhan Tanda Biotechnology Recent Developments
  7. 4.2 XIAN RUIXI
  8. 4.2.1 XIAN RUIXI RGD Peptide Company Information
  9. 4.2.2 XIAN RUIXI RGD Peptide Business Overview
  10. 4.2.3 XIAN RUIXI RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 XIAN RUIXI Product Portfolio
  12. 4.2.5 XIAN RUIXI Recent Developments
  13. 4.3 QYAOBIO
  14. 4.3.1 QYAOBIO RGD Peptide Company Information
  15. 4.3.2 QYAOBIO RGD Peptide Business Overview
  16. 4.3.3 QYAOBIO RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 QYAOBIO Product Portfolio
  18. 4.3.5 QYAOBIO Recent Developments
  19. 4.4 TGpeptide
  20. 4.4.1 TGpeptide RGD Peptide Company Information
  21. 4.4.2 TGpeptide RGD Peptide Business Overview
  22. 4.4.3 TGpeptide RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 TGpeptide Product Portfolio
  24. 4.4.5 TGpeptide Recent Developments
  25. 4.5 Merck KGaA
  26. 4.5.1 Merck KGaA RGD Peptide Company Information
  27. 4.5.2 Merck KGaA RGD Peptide Business Overview
  28. 4.5.3 Merck KGaA RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Merck KGaA Product Portfolio
  30. 4.5.5 Merck KGaA Recent Developments
  31. 4.6 Allpeptide
  32. 4.6.1 Allpeptide RGD Peptide Company Information
  33. 4.6.2 Allpeptide RGD Peptide Business Overview
  34. 4.6.3 Allpeptide RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Allpeptide Product Portfolio
  36. 4.6.5 Allpeptide Recent Developments
  37. 4.7 TargetMol Chemicals
  38. 4.7.1 TargetMol Chemicals RGD Peptide Company Information
  39. 4.7.2 TargetMol Chemicals RGD Peptide Business Overview
  40. 4.7.3 TargetMol Chemicals RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 TargetMol Chemicals Product Portfolio
  42. 4.7.5 TargetMol Chemicals Recent Developments
  43. 4.8 Santa Cruz Animal Health
  44. 4.8.1 Santa Cruz Animal Health RGD Peptide Company Information
  45. 4.8.2 Santa Cruz Animal Health RGD Peptide Business Overview
  46. 4.8.3 Santa Cruz Animal Health RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Santa Cruz Animal Health Product Portfolio
  48. 4.8.5 Santa Cruz Animal Health Recent Developments
  49. 4.9 PEPTIDE INSTITUTE
  50. 4.9.1 PEPTIDE INSTITUTE RGD Peptide Company Information
  51. 4.9.2 PEPTIDE INSTITUTE RGD Peptide Business Overview
  52. 4.9.3 PEPTIDE INSTITUTE RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 PEPTIDE INSTITUTE Product Portfolio
  54. 4.9.5 PEPTIDE INSTITUTE Recent Developments
  55. 4.10 Novatein Biosciences
  56. 4.10.1 Novatein Biosciences RGD Peptide Company Information
  57. 4.10.2 Novatein Biosciences RGD Peptide Business Overview
  58. 4.10.3 Novatein Biosciences RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Novatein Biosciences Product Portfolio
  60. 4.10.5 Novatein Biosciences Recent Developments
  61. 4.11 Enzo
  62. 4.11.1 Enzo RGD Peptide Company Information
  63. 4.11.2 Enzo RGD Peptide Business Overview
  64. 4.11.3 Enzo RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Enzo Product Portfolio
  66. 4.11.5 Enzo Recent Developments
  67. 4.12 Cell Guidance Systems
  68. 4.12.1 Cell Guidance Systems RGD Peptide Company Information
  69. 4.12.2 Cell Guidance Systems RGD Peptide Business Overview
  70. 4.12.3 Cell Guidance Systems RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Cell Guidance Systems Product Portfolio
  72. 4.12.5 Cell Guidance Systems Recent Developments
  73. 4.13 CD Bioparticles
  74. 4.13.1 CD Bioparticles RGD Peptide Company Information
  75. 4.13.2 CD Bioparticles RGD Peptide Business Overview
  76. 4.13.3 CD Bioparticles RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 CD Bioparticles Product Portfolio
  78. 4.13.5 CD Bioparticles Recent Developments
  79. 4.14 Bio-Techne
  80. 4.14.1 Bio-Techne RGD Peptide Company Information
  81. 4.14.2 Bio-Techne RGD Peptide Business Overview
  82. 4.14.3 Bio-Techne RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  83. 4.14.4 Bio-Techne Product Portfolio
  84. 4.14.5 Bio-Techne Recent Developments
  85. 4.15 BICO(Advanced BioMatrix)
  86. 4.15.1 BICO(Advanced BioMatrix) RGD Peptide Company Information
  87. 4.15.2 BICO(Advanced BioMatrix) RGD Peptide Business Overview
  88. 4.15.3 BICO(Advanced BioMatrix) RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  89. 4.15.4 BICO(Advanced BioMatrix) Product Portfolio
  90. 4.15.5 BICO(Advanced BioMatrix) Recent Developments
  91. 4.16 ApexBio Technology
  92. 4.16.1 ApexBio Technology RGD Peptide Company Information
  93. 4.16.2 ApexBio Technology RGD Peptide Business Overview
  94. 4.16.3 ApexBio Technology RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  95. 4.16.4 ApexBio Technology Product Portfolio
  96. 4.16.5 ApexBio Technology Recent Developments
  97. 4.17 AnaSpec
  98. 4.17.1 AnaSpec RGD Peptide Company Information
  99. 4.17.2 AnaSpec RGD Peptide Business Overview
  100. 4.17.3 AnaSpec RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  101. 4.17.4 AnaSpec Product Portfolio
  102. 4.17.5 AnaSpec Recent Developments
  103. 4.18 Abbiotec
  104. 4.18.1 Abbiotec RGD Peptide Company Information
  105. 4.18.2 Abbiotec RGD Peptide Business Overview
  106. 4.18.3 Abbiotec RGD Peptide Production Capacity, Value and Gross Margin (2021-2026)
  107. 4.18.4 Abbiotec Product Portfolio
  108. 4.18.5 Abbiotec Recent Developments
5 Global RGD Peptide Production by Region
  1. 5.1 Global RGD Peptide Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global RGD Peptide Production by Region: 2021-2032
  3. 5.2.1 Global RGD Peptide Production by Region: 2021-2026
  4. 5.2.2 Global RGD Peptide Production Forecast by Region (2027-2032)
  5. 5.3 Global RGD Peptide Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global RGD Peptide Production Value by Region: 2021-2032
  7. 5.4.1 Global RGD Peptide Production Value by Region: 2021-2026
  8. 5.4.2 Global RGD Peptide Production Value Forecast by Region (2027-2032)
  9. 5.5 Global RGD Peptide Market Price Analysis by Region (2021-2026)
  10. 5.6 Global RGD Peptide Production and Value, YOY Growth
  11. 5.6.1 North America RGD Peptide Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe RGD Peptide Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China RGD Peptide Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan RGD Peptide Production Value Estimates and Forecasts (2021-2032)
6 Global RGD Peptide Consumption by Region
  1. 6.1 Global RGD Peptide Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global RGD Peptide Consumption by Region (2021-2032)
  3. 6.2.1 Global RGD Peptide Consumption by Region: 2021-2026
  4. 6.2.2 Global RGD Peptide Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America RGD Peptide Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.4 Europe
  11. 6.4.1 Europe RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  12. 6.4.2 Europe RGD Peptide Consumption by Country (2021-2032)
  13. 6.4.3 Germany
  14. 6.4.4 France
  15. 6.4.5 U.K.
  16. 6.4.6 Italy
  17. 6.4.7 Netherlands
  18. 6.5 Asia Pacific
  19. 6.5.1 Asia Pacific RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  20. 6.5.2 Asia Pacific RGD Peptide Consumption by Country (2021-2032)
  21. 6.5.3 China
  22. 6.5.4 Japan
  23. 6.5.5 South Korea
  24. 6.5.6 India
  25. 6.5.7 Australia
  26. 6.5.8 China Taiwan
  27. 6.5.9 Southeast Asia
  28. 6.6 South America, Middle East & Africa
  29. 6.6.1 South America, Middle East & Africa RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East & Africa RGD Peptide Consumption by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 Argentina
  33. 6.6.5 Chile
  34. 6.6.6 Turkey
  35. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global RGD Peptide Production by Type (2021-2032)
  2. 7.1.1 Global RGD Peptide Production by Type (2021-2032) & (L)
  3. 7.1.2 Global RGD Peptide Production Market Share by Type (2021-2032)
  4. 7.2 Global RGD Peptide Production Value by Type (2021-2032)
  5. 7.2.1 Global RGD Peptide Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global RGD Peptide Production Value Market Share by Type (2021-2032)
  7. 7.3 Global RGD Peptide Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global RGD Peptide Production by Application (2021-2032)
  2. 8.1.1 Global RGD Peptide Production by Application (2021-2032) & (L)
  3. 8.1.2 Global RGD Peptide Production Market Share by Application (2021-2032)
  4. 8.2 Global RGD Peptide Production Value by Application (2021-2032)
  5. 8.2.1 Global RGD Peptide Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global RGD Peptide Production Value Market Share by Application (2021-2032)
  7. 8.3 Global RGD Peptide Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 RGD Peptide Value Chain Analysis
  2. 9.1.1 RGD Peptide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 RGD Peptide Production Mode & Process
  5. 9.2 RGD Peptide Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 RGD Peptide Distributors
  8. 9.2.3 RGD Peptide Customers
10 Global RGD Peptide Analyzing Market Dynamics
  1. 10.1 RGD Peptide Industry Trends
  2. 10.2 RGD Peptide Industry Drivers
  3. 10.3 RGD Peptide Industry Opportunities and Challenges
  4. 10.4 RGD Peptide Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst